Quarterhill Inc

Sound bite for Twitter and StockTwits is: Tech Sector Stock. Results of stock price testing is that the stock price is probably cheap. Debt Ratios are fine for 2023, but have deteriorated a lot for the first 2 quarters of 2024. The Dividend Payout Ratios (DPR) mostly not calculable because of earnings losses and negative cash flows. The current dividend yield is 0% with dividends being cut in 2022 and cancelled in 2023. See my spreadsheet on Quarterhill Inc.

Is it a good company at a reasonable price? The good news is that insiders are buying. The other good news is that the stock price would seem to be cheap. However, being cheap does not mean that a stock is a good buy. They are having trouble getting earning money. They have suspended the dividends. This is not good news. Analysts expect it to do well in the future. However, buying this company is a risk and you should not use money you cannot afford to lose. This company has only occasionally given a decent return for shareholders, so you have to wonder if it is worth the risks.

I do not own this stock of Quarterhill Inc (TSX-QTRH, OTC-QTRHF), but I used to. I bought this company in 2000 as WiLan Inc. (TSX-WIN, OTC-WILN. It was an up and coming company in communications. I sold it in 2006 after losing most of my investment. This stock has never recovered from the bubble that occurred in 2000. I lost all hope of ever making any money on this stock. The other thing is that they completely refocused their company to earn money on their patents. Since then, they have reinvented themselves a number of times.

When I was updating my spreadsheet, I noticed Revenue for 2022 was restated because of the sale of Wi-Lan Inc. See notice on Newswire. I also notice that although they cancelled the dividend, insiders are buying. Of the insiders buying that I follow is the CEO, CFO, Chairman and another director.

If you had invested in this company in December 2013, for $1,001.10 you would have bought 282 shares at $3.55 per share. In December 2023, after 10 years you would have received $253.10 in dividends. The stock would be worth $549.90. Your total return would have been $803.00. This would be a total loss of 2.67% per year with 5.82% from capital loss and 3.14% from dividends.

Cost	Tot. Cost	Shares	Years	Dividends	Stock Val	Tot Ret
$3.55	$1,001.10	282	10	$253.10	$549.90	$803.00

The current dividend yield is 0% with dividends being cut in 2022 and cancelled in 2023.

The Dividend Payout Ratios (DPR) mostly not calculable because of earnings losses and negative cash flows. The DPR for 2023 for Earnings per Share (EPS) cannot be calculated because of earning losses. The DPR for 2023 for Cash Flow per Share (CFPS) cannot be calculated because of a negative cash flow with 5 year coverage good at 29%. The DPR for 2023 for Free Cash Flow (FCF) is negative due to a negative FCF with 5 year coverage at 52%. There is no agreement on what the FCF is. However, in 2023, all sites agreed it was negative.

Item	Cur	5 Years
EPS	N/C	N/C
CFPS	N/C	29.47%
FCF	-31.49%	52.02%

Debt Ratios are fine for 2023, but have deteriorated a lot for the first 2 quarters of 2024. The Long Term Debt/Market Cap Ratio for 2023 is good at 0.33 and currently at 0.49. The Liquidity Ratio for 2023 is good at 2.93 and is low at 1.37 currently. If you added in Cash Flow after dividends, the ratios are fine at 2.86 and currently it is negative because lack of cash flow this year. The Debt Ratio for 2023 is good at 2.34 and 2.29 currently. The Leverage and Debt/Equity Ratios for 2023 are good at 1.75 and 0.75 and currently at 1.77 and 0.44.

Type	Year End	Ratio Curr
Lg Term R	0.33	0.49
Intang/GW	0.64	0.57
Liquidity	2.93	1.37
Liq. + CF	2.86	-6.98
Debt Ratio	2.34	2.29
Leverage	1.75	1.77
D/E Ratio	0.75	0.77

The Total Return per year is shown below for years of 5 to 25 to the end of 2023 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.
2018	5	-24.21%	10.82%	7.95%	2.86%
2013	10	-22.26%	-2.67%	-5.82%	3.14%
2008	15	-4.83%	9.23%	2.95%	6.28%
2003	20		-1.81%	-4.06%	2.26%
1998	25		3.73%	1.05%	2.67%

The Total Return per year is shown below for years of 5 to 22 to the end of 2023 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.
2018	5	-23.74%	11.32%	8.37%	2.95%
2013	10	-23.93%	-5.20%	-7.90%	2.70%
2008	15	-6.39%	7.97%	1.70%	6.28%
2003	20		-1.20%	-3.74%	2.54%
2001	22		0.03%	-2.49%	2.52%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 8.31, 12.97 and 16.34. The corresponding 10 year ratios are 10.96, 16.59 and 21.70. The corresponding historical ratios are negative and therefore useless. The current ratio is negative and cannot be used. The P/E Ratio for 2024 is 82.11 based on a stock price of $1.56 and 2025 EPS estimate of $0.02. This is way above the 10 year ratios. This stock price testing suggests that the stock price is relatively expensive

I get a Graham Price of $0.71. The 10-year low, median, and high median Price/Graham Price Ratios are 0.56, 0.98 and 1.45. The current P/GP Ratio is 2.19 based on a stock price of $1.56. This ratio is above the high ratio for the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Book Value per Share Ratio of 0.94. The current P/B Ratio is 1.32 based on a stock price of $1.56, Book Value of 136M, and Book Value per Share of $1.18. The current ratio is 41% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. Although the ratio is 1.32 is not a very high one, generally speaking.

I get a 10-year median Price/Cash Flow per Share Ratio of 6.43. The current ratio is 7.43 based on Cash Flow for the last 12 months of $24.2M, Cash Flow per Share of $0.21 and a stock price of $1.56. The current ratio is 17% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I cannot do any dividend yield testing because the dividends have been cancelled.

The 10-year median Price/Sales (Revenue) Ratio is 1.83. The current P/S Ratio is 0.81 based on a stock price of $1.56, Revenue estimate for 2024 of $220.9M and Revenue per Share of $1.91. The current ratio is 56% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is probably cheap. The P/S Ratio test is one of the few that is a good test. It says that the stock price is relatively cheap. The other two tests that are ok is the P/B Ratio test that says the stock price is expensive and the P/CF Ratio test that says that the stock price is relatively reasonable but above the median. I am going with the P/S Ratio test.

When I look at analysts’ recommendations, I find Strong Buy (1) and Buy (2). The consensus would be a Strong Buy. The 12 month stock price consensus is $2.18 with a high of $2.30 and low of $2.00. The 12 month stock price of $2.18 implies a total return of $39.74% all from capital gains.

Most analysts on Stock Chase for 2024 like what this company is doing. Stock Chase gives this stock 4 stars out of 5. Christopher Liew on Motley Fool in July 2024 thought that this is a low cost stock that is perfect for getting started in the stock market. Christopher Liew on Motley Fool also suggested this stock to get into in January 2023. The company put out a Press Release about their 2023 annual results. The company put out a Press Release about their second quarter of 2024.

Simply Wall Street via Yahoo Finance reviews this stock. Simply Wall Street has one warning on this stock of currently unprofitable and not forecast to become profitable over the next 3 years. Simply Wall Street gives this stock 2 and one half stars out of 5.

Quarterhill Inc is focused on the acquisition, management, and growth of companies in the intelligent transportation systems (ITS) and innovation and licensing industries. It operates in two segments Licensing, and Intelligent Transportation Systems. Its geographical segments are the United States, Canada, Chile, China, Korea, Singapore, Taiwan, Thailand, Ukraine, and the Rest of the world. The majority of the revenue comes from the United States. Its web site is here Quarterhill Inc.

The last stock I wrote about was about was Finning International Inc (TSX-FTT, OTC-FINGF) ... learn more. The next stock I will write about will be Chesswood Group Ltd (TSX-CHW, OTC-CHWWF) ... learn more on Wednesday, November 13, 2024 around 5 pm. Tomorrow on my other blog I will write about Trump and Canada .... learn more on Tuesday, November 12, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures. November 12, 2024

Finning International Inc

Sound bite for Twitter and StockTwits is: Dividend Growth Industrial. Results of stock price testing is that the stock price is probably still reasonable. Debt Ratios are probably fine, but the company has a lot of debt. The Dividend Payout Ratios (DPR) are good. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Finning International Inc.

Is it a good company at a reasonable price? A lot of analysts seem to like this stock. It has done well in most years for its shareholders. It is a dividend growth stock. It does have a lot of debt. The stock price seems to be relatively reasonable at this time.

I do not own this stock of Finning International Inc (TSX-FTT, OTC-FINGF). When I was in the market to buy an industrial stock in this area in 2007, I look at this stock was well as Toromont Industries (TSX-TIH). At the time I liked Toromont better, so that is what I bought.

When I was updating my spreadsheet, I noticed that my Toromont Industries Ltd (TSX-TIH, OTC-TMTNF) has done better than Finning. They are both into moving heavy equipment. When I wanted to buy another industrial (2007) and I looked at both Toromont and Finning and decided to go with Toromont. See Toromont Long Term returns in the chart below and see Finning further down this page. It is not so much that Finning has done badly, but Toromont has done a lot better and I am glad I went with Toromont.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.	check
2018	5	13.81%	18.25%	16.43%	1.82%	18.25%
2013	10	12.66%	17.75%	15.85%	1.89%	17.75%
2008	15	11.17%	17.08%	15.10%	1.98%	17.08%
2003	20	13.71%	14.71%	12.97%	1.73%	14.71%
1998	25	12.97%	15.37%	13.57%	1.80%	15.37%
1993	30	15.65%	18.80%	16.20%	2.59%	18.80%
1990	33	14.66%	22.61%	18.55%	4.06%	22.61%

If you had invested in this company in December 2013, for $1,004.55 you would have bought 37 shares at $27.15 per share. In December 2023, after 10 years you would have received $299.29 in dividends. The stock would be worth $1,417.84. Your total return would have been $1,717.13. This would be a total return of 6.04% per year with 3.51% from capital gain and 2.54% from dividends.

Cost	Tot. Cost	Shares	Years	Dividends	Stock Val	Tot Ret
$27.15	$1,004.55	37	10	$299.29	$1,417.84	$1,717.13

The current dividend yield is moderate with dividend growth low. The current dividend yield is moderate (2% to 4% ranges) at 2.66%. The 5 and 10 year median dividend yields are also moderate at 2.82% and 2.79%. The historical median dividend yield is low (below 2%) at 1.98%.

The Dividend Payout Ratios (DPR) are good. The DPR for 2023 for Earnings per Share (EPS) is good at 28% with 5 year coverage at 37%. The DPR for 2023 for Adjusted Earnings per Share (AEPS) is good at 25% with 5 year coverage at 43%. The DPR for 2023 for Cash Flow per Share (CFPS) is good at 11% with 5 year coverage at 15%. The DPR for 2023 for Free Cash Flow (FCF) is too high at 1825% with 5 year coverage at 65%. However, no site agrees what the FCF is and there are big disparities in what sites say. I am not considering FCF.

Item	Cur	5 Years
EPS	27.85%	36.94%
AEPS	25.22%	42.94%
CFPS	11.17%	14.80%
FCF	1825.00%	65.24%

Debt Ratios are probably fine, but the company has a lot of debt. The Long Term Debt/Market Cap Ratio for 2023 is good at 0.17 and currently at 0.23. The Liquidity Ratio for 2023 is fine at 1.41 and 1.55 currently. If you added in Cash Flow after dividends, the ratios are fine at 1.53 and currently at 1.76. The Debt Ratio for 2023 is fine at 1.44 and 1.74 currently. The Leverage and Debt/Equity Ratios for 2023 are too high at 3.01 and 2.00 and currently at 3.12 and 2.11. I prefer these ratios to be under 3.00 and under 2.00

Type	Year End	Ratio Curr
Lg Term R	0.17	0.23
Intang/GW	0.12	0.10
Liquidity	1.41	1.55
Liq. + CF	1.44	1.74
Debt Ratio	1.50	1.48
Leverage	3.01	3.12
D/E Ratio	2.00	2.11

The Total Return per year is shown below for years of 5 to 36 to the end of 2023. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.
2018	5	4.53%	13.07%	9.99%	3.07%
2013	10	5.14%	6.04%	3.51%	2.54%
2008	15	5.69%	9.90%	6.82%	3.08%
2003	20	12.12%	7.17%	4.80%	2.37%
1998	25	9.59%	11.04%	8.09%	2.95%
1993	30	10.84%	9.66%	7.21%	2.45%
1988	35	7.44%	10.55%	7.91%	2.64%
1987	36	8.09%	11.00%	8.19%	2.81%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 9.16, 13.73 and 16.90. The corresponding 10 year ratios are 12.26, 14.96 and 18.12. The corresponding historical ratios are 12.11, 15.70, and 19.00. The current P/E Ratio is 10.50 based on a stock price of $41.38 and EPS estimate for 2024 of $3.94. The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 9.89, 14.84 and 15.99. The corresponding 10 year ratios are 13.14, 17.09 and 19.11. The current ratio is 10.56 based on AEPS estimate for 2024 of $3.92. This ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $39.71. The 10-year low, median, and high median Price/Graham Price Ratios are 1.01, 1.23 and 1.45. The current P/GP Ratio is 1.04 based on a stock price of $41.38. This ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Book Value per Share Ratio of 2.21. The current P/B Ratio is 2.31 based on a stock price of $41.38, Book Value of $2,575M and Book Value per Share of $17.88. The current ratio is 5% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 14.36. The current ratio is 7.31 based on Cash Flow per Share estimate for 2024 of $5.66, Cash Flow of $816M and a stock price of $41.38. The current ratio is 49% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 1.98%. The current dividend yield is 2.66% based on dividends of $1.075 and a stock price of $41.38. The current ratio is 31% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

I get a 10 year median dividend yield of 2.79%. The current dividend yield is 2.66% based on dividends of $1.075 and a stock price of $41.38. The current ratio is 5% below the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median.

The 10-year median Price/Sales (Revenue) Ratio is 0.65. The current P/S Ratio is 0.59 based on Revenue estimate for 2024 of $10,075M, Revenue per Share of $69.96 and a stock price of $41.38. The current ratio is 10% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is probably still reasonable. The 10 year dividend yield test says the stock price is relatively reasonable but above median. This historical dividend yield test says the stock price is cheap. The P/S Ratio test says that the stock price is relatively reasonable. Most of the rest of the testing is saying that the stock price is cheap or reasonable except for the P/B Ratio test.

When I look at analysts’ recommendations, I find Strong Buy (4), and Buy (5). The consensus would be a Strong Buy. The 12 months stock price consensus is $49.44 with a high of $53.00 and low of $45.00. The consensus stock price of $49.44 implies a total return of 22.14% with 19.48% from capital gains and 2.66% from dividends based on a current stock price of $41.38.

Most analyst on Stock Chase like this stock and says it is their top pick. There is one Do Not Buy and that analysts said she would rather buy Cat who makes the machinery and the Distributor. Stock Chase gives this stock 4 stars out of 5. Amy Legate-Wolfe on Motley Fool say this stock jumped on strong first quarter and 10% dividend increase. Kay Ng onMotley Fool say Finning is a cyclical dividend stock that offers decent long term returns. The company put out a Press Release about their fourth quarter of 2023. The company put out a Press Release for their second quarter of 2024.

Simply Wall Street via Yahoo Finance reviews this stock. Simply Wall Street thinks this stock is undervalued and its fair value of $62.43. Simply Wall Street gives this stock 4 stars out of 5. It has one warning of debt is not well covered by operating cash flow.

Finning International Inc is a dealer and distributor of heavy-duty machinery and parts of the Caterpillar brand. The company operates in Canada, South America, UK and Ireland, and others. Its web site is here Finning International Inc.

The last stock I wrote about was about was Veren Inc (TSX-VRN, NYSE-VRN) ... learn more. The next stock I will write about will be Quarterhill Inc (TSX-QTRH, OTC-QTRHF) ... learn more on Monday, November 11, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Veren Inc

ound bite for Twitter and StockTwits is: Dividend Paying Resource. Results of stock price testing is that the stock price is suggests that the stock price is relatively cheap. Debt Ratios are fine. The Dividend Payout Ratios (DPR) are currently good. The current dividend yield is good with dividend growth low to negative. See my spreadsheet on Veren Inc.

Is it a good company at a reasonable price? This is a resource stock and is therefore risky. It would also by cyclical. If you are buying for dividends, they be unstable. A positive is insider buying. Personally, I tend not be buy resource stocks, or buy them for a short hold. I never consider them a long term hold. If you like resource stocks currently, this is selling cheap.

I do not own this stock of Veren Inc (TSX-VRN, NYSE-VRN). I got this idea to look into this stock from another blogger, My Own Advisor and his November 2012 blog entry on great Canadian dividend paying stocks. I also noticed that several people at the Toronto Money Show of 2013 mentioned this stock.

When I was updating my spreadsheet, I noticed Crescent Point Energy Corp (TSX-CPG, NYSE-CPG) has changed its name and symbols to Veren Inc (TSX-VRN, NYSE-VRN) effective May 15. See news item on Newswire.

When I was updating my spreadsheet, I noticed that all the officers I follow, including CEO and CFO have increased their shares in the company and 2 of the 3 directors I follow have increased their shares in the company. These increases are over the past year.

If you had invested in this company in December 2013, for $1,031.25 you would have bought 25 shares at $41.25 per share. In December 2023, after 10 years you would have received $177.11 in dividends. The stock would be worth $229.75. Your total return would have been $406.86. This would be a total loss of 11.38% per year with 13.94% from capital loss and 2.57% from dividends.

Cost	Tot. Cost	Shares	Years	Dividends	Stock Val	Tot Ret
$41.25	$1,031.25	25	10	$177.11	$229.75	$406.86

Compared above with the last 5 years. If you had invested in this company in December 2018, for $1,001.28 you would have bought 242 shares at $4.14 per share. In December 2023, after 5 years you would have received $192.27 in dividends. The stock would be worth $2,223.98. Your total return would have been $2,416.25. This would be a total return of 19.52% per year with 17.29% from capital loss and 2.23% from dividends.

Cost	Tot. Cost	Shares	Years	Dividends	Stock Val	Tot Ret
$4.14	$1,001.88	242	5	$192.27	$2,223.98	$2,416.25

The current dividend yield is good with dividend growth low to negative. The current dividend yield is good (5% to 6% ranges) at 6.63%. The 5 year median dividend yield is low (below 1%) at 0.84%. The 10 year median dividend yield is moderate (2% to 4% ranges) at 2.95%. The historical median dividend yield is good at 6.96%.

The dividend growth over the past 5 years is low (below 8% per year) at 1.1% per year. However, this holds a lot of variations. Dividends were cut in 2019 by 89% and then another 75% in 2020. Dividends were rammed up in 2022 and the difference in dividends between 2021 and 2022 was an increase of 2833%. Dividends were increased in 2023 another 73%. The last dividend increase was for 15% and it was in 2024. Also, this company used to be an income trust which can have higher dividends than corporations. The company kept dividends flat for a number of years after the change to a corporation before decreasing dividends.

The Dividend Payout Ratios (DPR) are currently good. The DPR for 2023 for Earnings per Share (EPS) is good at 45% with 5 year coverage high at 72%. The DPR for 2023 for Adjusted Earnings per Share (AEPS) is good at 27% with 5 year coverage at 11%. The DPR for 2023 for Adjusted Funds from Operations (AFFO) is good at 9% with 5 year coverage at 5%. The DPR for 2023 for Cash Flow per Share (CFPS) is good at 12% with 5 year coverage at 5%. The DPR for 2023 for Free Cash Flow (FCF) is good at 22% with 5 year coverage at 14%.

Item	Cur	5 Years
EPS	44.90%	72.23%
AEPS	27.47%	11.32%
AFFO	8.91%	5.05%
CFPS	12.86%	5.25%
FCF	21.73%	13.82%

Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2023 is fine at 0.66 and currently at 0.59. The Liquidity Ratio for 2023 is too low at 0.76 and 1.29 currently. If you added in Cash Flow after dividends, the ratios are fine at 2.15 and currently at 2.92. The Debt Ratio for 2023 is good at 2.16 and 2.23 currently. The Leverage and Debt/Equity Ratios for 2023 are good at 1.53 and 0.86 and currently at 1.82 and 0.82.

Type	Year End	Ratio Curr
Lg Term R	0.66	0.59
Intang/GW	0.05	0.05
Liquidity	0.76	1.29
Liq. + CF	2.15	2.92
Liq. CF. DB	2.97	4.19
Debt Ratio	2.16	2.23
Leverage	1.86	1.82
D/E Ratio	0.86	0.82

The Total Return per year is shown below for years of 5 to 22 to the end of 2023. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.
2018	5	1.09%	19.52%	17.29%	2.33%
2013	10	-17.99%	-11.38%	-13.94%	2.57%
2008	15	-11.99%	3.06%	-6.22%	9.28%
2003	20	-2.87%	16.11%	-1.81%	17.92%
2001	22		37.53%	4.39%	33.14%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 0.74, 1.19 and 1.64. The corresponding 10 year ratios are negative and unusable. The corresponding historical ratios are 2.88, 6.20 and 9.52. The current P/E Ratio is 19.50 based on a stock price of $7.45 and EPS estimate for 2024 of $0.38. The ratio is way above the 5 year ratios, which are very low due to earnings losses. However, a ratio is 19.50 is on the high side.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 04.26, 6.11 and 7.96. The corresponding 10 year ratios are 6.86, 12.39 and 14.98. The current P/AEPS Ratio is 4.84 based on a stock price of $7.45 and AEPS estimate for 2024 of $1.54. The current ratio is below the low ratio for the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Funds from Operations (AFFO) data. The 5-year low, median, and high median Price/ Adjusted Funds from Operations Ratios 1.18, 2.17 and 2.71. The corresponding 10 year ratios are 1.86, 2.54 and 3.55. The current P/AFFO Ratio is 2.06 based on a stock price of $7.45 and AFFO estimate for 2024 of $3.62. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $17.87. The 10-year low, median, and high median Price/Graham Price Ratios are 0.37, 0.64 and 0.82. The current P/GP Ratio is 0.42 based on a stock price of $7.45. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Book Value per Share Ratio of 0.79. The current P/B Ratio is 0.81 based on a Book Value of $6,868M, Book Value per Share of $11.08 and a stock price of $7.45. The current ratio is 2% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 2.68. The current P/CF Ratio is 1.99 based on a stock price of $7.45, Cash Flow per Share estimate for 2024 of $3.74 and a Cash Flow of $2,315M. The current ratio is 26% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 6.96%. The current dividend yield is 6.17% based on dividends of $0.46 and a stock price of $7.45. The current yield is 11% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median. Since this company used to be an income trust with high dividend yields, this would not be a good test.

I get a 10 year median dividend yield of 2.95%. The current dividend yield is 6.17% based on dividends of $0.46 and a stock price of $7.45. The current yield is 109% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

The 10-year median Price/Sales (Revenue) Ratio is 1.37. The current P/S Ratio is 1.09 based on a stock price of $7.45, Revenue estimate for 2024 of $4,224 and Revenue per Share of $6.81. The current ratio is 20.2% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is suggests that the stock price is relatively cheap. The 10 year dividend yield is saying that the stock price is cheap. This is confirmed by the P/S Ratio test. The rest of the testing says that the stock price is cheap or reasonable.

When I look at analysts’ recommendations, I find Strong Buy (8), Buy (5), and Hold (1). The consensus would be a Strong Buy. The 12 months stock price consensus is $11.82 with a high of $14.00 and low of $10.00. The consensus stock price of $11.82 implies a total return of 64.83 with 58.66% from capital gains and 6.17% from dividends based on a current stock price of $7.45.

There are lots of analyst comments on Stock Chase for this stock. Most are positive. However, one analyst said that there were better names elsewhere. Stock Chase gives this stock 4 stars out of 5. Jitendra Parashar on Motley Fool says Canadian Stocks are decline with this stock tanking. Rajiv Nanjapla on Motley Fool in December 2023 felt this stock could give you superior long term returns. The company put out a press release via Newswire about their fourth quarter results for 2023. The company put out a Press Release about their third quarter of 2024.

Simply Wall Street via Yahoo Finance reviews this stock. Simply Wall Street gives this stock 3 and one half stars out of 5. They have 4 warnings out on this stock of earnings are forecast to decline by an average of 2.4% per year for the next 3 years; shareholders have been diluted in the past year; has a high level of debt; and unstable dividend track record.

Veren Inc is an oil producer company. It is engaged in acquiring, developing, and holding interests in petroleum assets operations across western Canada. Its web site is here Veren Inc.

The last stock I wrote about was about was Innergex Renewable Energy (TSX-INE, OTC-INGXF) ... learn more. The next stock I will write about will be Finning International Inc (TSX-FTT, OTC-FINGF) ... learn more on Friday, November 8, 2024 around 5 pm. Tomorrow on my other blog I will write about Something to Buy November 2024.... learn more on Thursday, November 7, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Innergex Renewable Energy

Sound bite for Twitter and StockTwits is: Dividend Paying Utility. Results of stock price testing is that the stock price is probably cheap. Debt Ratios are generally awful and debt it way too high. The Dividend Payout Ratios (DPR) are only positive for Cash Flow, but are really showing that dividends are not well covered. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Innergex Renewable Energy.

Is it a good company at a reasonable price? This stock is probably cheap, but that does not make it a good buy. Dividends were recently cut. The company is not expected to have much in earnings anytime soon. Personally, I like companies that have earnings and increasing dividends. It was probably wise for the company to cut their dividends. This is not the sort of company I would be interested in.

I do not own this stock of Innergex Renewable Energy (TSX-INE, OTC-INGXF). In 2006 I bought Innergex Power on a buy rating and favorable report from TD although it has only been going from 2003. In 2008 I sold Innergex as I did not think that it is a stock I want to hold as dividend increased less than the rate of inflation.

When I was updating my spreadsheet, I noticed that there has been little growth over the past 5 and 10 years for this stock. You have a bit of Revenue growth and some Stock Price growth and that is it. See below.

In the chart below, I am showing 5 and 10 year total growth and per year growth in columns 3 and 4. Column 5 shows growth expected over 12 months to the first quarter in 2024 and expected growth over this year.

Yr	Item	Tot. Gwth	Per Year	Gwth	Coverage
5	Revenue Growth	68.20%	10.96%	1.30%	<-12 mths
5	AEPS Growth	-104.76%	N/C	-1200.00%	<-12 mths
5	Net Income Growth	-401.15%	N/C	-26.83%	<-12 mths
5	Cash Flow Growth	42.25%	7.30%	-13.89%	<-12 mths
5	Dividend Growth	6.67%	1.30%	-37.50%	<-12 mths
5	Stock Price Growth	-26.71%	-6.03%	3.48%	<-12 mths
10	Revenue Growth	389.20%	17.21%	7.02%	<-this year
10	AEPS Growth	-102.33%	N/C	-1700.00%	<-this year
10	Net Income Growth	-316.70%	N/C	-78.47%	<-this year
10	Cash Flow Growth	143.57%	9.31%	-9.83%	<-this year
10	Dividend Growth	24.14%	2.19%	-50.00%	<-this year
10	Stock Price Growth	-13.30%	-1.42%	30.58%	<-this year

The current dividend yield is moderate with dividend growth low. The current dividend yield is moderate (2% to 4% ranges) at 4.04%. The 5 and 10 year median dividend yields are also moderate at 4.14% and 4.76%. The historical median dividend yield is good (5% to 6% ranges) at 5.74%. This company used to be an income trust and these companies have much higher dividend yields than corporations. Dividend did drop when this company became a corporation. The dividends are increase at a low rate (below 8% per year) at 1.30% per year over the past 5 years. The last dividend change was in 2024 and dividends were decreased by 50%.

The Dividend Payout Ratios (DPR) are only positive for Cash Flow, but are really showing that dividends are not well covered. The DPR for 2023 for Earnings per Share (EPS) is cannot be calculated because of earning losses. The DPR for 2023 for Adjusted Earnings per Share (AEPS) cannot be calculated because of Adjusted EPS losses with 5 year coverage high at 109%. The DPR for 2023 for Cash Flow per Share (CFPS) is good at 24% with 5 year coverage at 32%. The DPR for 2023 for Free Cash Flow (FCF) is not valid because both the FCF is negative. There is no agreement on what the FCF is, but all say it is negative.

Item	Cur	5 Years
EPS	N/C	N/C
AEPS	N/C	109.15%
CFPS	24.40%	31.65%
FCF	-38.53%	-165.93%

Debt Ratios are generally awful and debt it way too high. The Long Term Debt/Market Cap Ratio for 2023 is very high at 3.21and currently at 2.93. Investors do not seem to think that the The Liquidity Ratio for 2023 is good at 1.55 and 1.50 currently. If you added in Cash Flow after dividends, the ratios are fine at 1.53 and currently at 1.76. The Debt Ratio for 2023 is good at 1.68 and 1.68 currently. The Leverage and Debt/Equity Ratios for 2023 are good at 1.47 and 0.47 and currently at 1.46 and 0.46.

Type	Year End	Ratio Curr
Lg Term R	3.21	2.93
Intang/GW	0.77	0.72
Liquidity	0.91	0.57
Liq. + CF	0.56	0.75
Liq. CF DB	2.45	2.29
Debt Ratio	1.16	1.19
Leverage	7.42	6.14
D/E Ratio	6.42	5.14

The Total Return per year is shown below for years of 5 to 20 to the end of 2023. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.
2018	5	1.30%	0.39%	-6.03%	6.42%
2013	10	2.19%	5.26%	-1.42%	6.67%
2008	15	0.33%	11.27%	2.55%	8.72%
2003	20	0.72%	8.02%	0.52%	7.49%

The 5-year low, median, and high median Price/Earnings per Share Ratios are negative and useless. The corresponding 10 year ratios are also negative and useless. The corresponding historical ratios are negative and useless. I can do not stock price testing here.

I also have Adjusted Earnings per Share (AEPS) data. However, the 10 year P/AEPS Ratios are negative and useless. There are 10 year ratios, but they are very high. The current ratio is negative because the AEPS is expected to be negative again this year. I can do not stock price testing here.

Because the EPS and AEPS are negative, I cannot do any Graham Price testing.

I get a 10-year median Price/Book Value per Share Ratio of 3.81. The current P/B Ratio is 1.35 based on a Book Value of $1,339M, Book Value per Share of $6.58 and a stock price of $8.92. The current ratio is 62% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I also have a Book Value per Share estimate for 2024 of $4.06. This implies a ratio of 2.20 based on a stock price of $8.92 and Book Value of $826M. This ratio is 23% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get a 10-year median Price/Cash Flow per Share Ratio of 10.52. The current ratio is 6.76 based on Cash Flow per Share estimate for 2024 of $1.32, Cash Flow of $269M and a stock price of $8.92. The current ratio is 36% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 5.74%. The current dividend yield is 4.04% based on dividends of $0.36 and a stock price of $8.92. The current dividend yield is 30% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. The problem with this test is that dividends have recently been cut.

I get a 10 year median dividend yield of 4.76%. The current dividend yield is 4.04% based on dividends of $0.36 and a stock price of $8.92. The current dividend yield is 15% below the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median. The problem with this test is that dividends have recently been cut.

The 10-year median Price/Sales (Revenue) Ratio is 4.26. The current P/S Ratio is 1.75 based on Revenue estimate for 2024 of $1,038M, Revenue per Share of $5.10 and a stock price of $8.92. The current ratio is 63% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is probably cheap. The 10 year dividend yield test says that the stock price is reasonable, but above the median. However, the dividends were recently cut. This is, of course, a bad sign. The P/S Ratio testing is saying that the stock price is relatively cheap. Since the stock has not much in the way of earnings, testing for earnings cannot be done. Other testing I can do shows that the stock price is relatively cheap.

When I look at analysts’ recommendations, I find Buy (4), and Hold (5). The consensus would be a Buy. The 12 months consensus stock price is $12.00 with a high of $17.00 and low of $10.00. The consensus stock price of $12.00 implies a total return of 38.57% with 34.53% from capital gains and 4.04% from dividends based on a current stock price of $8.92.

There are few analysts on Stock Chase following this stock. In past years there were Do Not Buy recommendations. The worries are operating weakness and high debt. Stock Chase gives this stock 3 stars out of 5. Adam Othman on Motley Fool thinks you should buy this stock as it is incredibly cheap. Amy Legate-Wolfe on Motley Fool also thinks you should be buy this because it is cheap. The company put out a press release via Newswire on their fourth quarter of 2024 results. The company put out a press release via Newswire about their second quarter of 2024.

Simply Wall Street via Yahoo Finance reviews this stock. They have two warnings of dividend of 3.96% is not well covered by earnings or free cash flows; and has less than 1 year of cash runway. Simply Wall Street gives this stock 2 and one half stars out of 5.

Innergex Renewable Energy Inc is an independent Canadian renewable power producer. It develops, acquires, owns, and operates hydroelectric, wind, and solar facilities in Canada, the United States, France, and Chile. Its web site is here Innergex Renewable Energy.

The last stock I wrote about was about was Johnson and Johnson (NYSE-JNJ) ... learn more. The next stock I will write about will be Veren Inc (TSX-VRN, NYSE-VRN) ... learn more on Wednesday, November 6, 2024 around 5 pm. Tomorrow on my other blog I will write about Dividend Stocks November 2024 learn more on Tuesday, November 5, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Johnson and Johnson

Sound bite for Twitter and StockTwits is: Dividend Growth Consumer. Results of stock price testing is that the stock price is pointing to a reasonable price that is below the median. Debt Ratios are fine, but Liquidity Ratio is low. The Dividend Payout Ratios (DPR) are fine. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Johnson and Johnson.

Is it a good company at a reasonable price? This stock is part of the US Dividend Aristocrats and with its shareholders have received increasing dividends over a long period of time. It has not been a great performer over time, but it has been an acceptable one. If you buy US stocks, you should really use a US$ account so you can move money into and out of US$ when you chose. The problem with the TSX is that there are few Health Care stocks to chose from and this is a Health Care stock. People buy Health Care stocks for diversification. The stock price seems reasonable at this time.

I do not own this stock of Johnson and Johnson (NYSE-JNJ). As Canadians, we are told we should be buying US stocks for our portfolio. It is often recommended that we have at least 25% of our portfolio in US stocks. I have never followed this, although I have tried dipping into the US market, but I have never made any money there. I bought some of this stock in June 2005 and realized a year later, in June of 2006 that it was going nowhere for me and sold. I lost almost 17% of my investment. When I bought in 2005, all the analysts were saying that it was a good buy at that time.

When I was updating my spreadsheet, I noticed both EPS and Net Income went up a lot in 2023 because of earnings from discontinued operations. They are expected to go closer to values of 2022 in 2024. For example, EPS climbed 104% in 2023 and is expected to go down by 47% in 2024. However, the EPS expected in 2024 is 7% higher than in 2022. Also, Revenue went down in 2023 because of the spin-off of Kenvue. See the Press Release. Revenue was down by 10% in 2023 and is expected to rise by 4% in 2024.

If you had invested in this company in December 2013, for $1,007.47 you would have bought 11 shares at $91.59 per share. In December 2023, after 10 years you would have received $404.69 in dividends. The stock would be worth $1,724.14. Your total return would have been $2,128.83. This would be a total return of 8.63% per year with 5.52% from capital gain and 3.11% from dividends. This is buying the stock in the US market using a US$ account.

Cost	Tot. Cost	Shares	Years	Dividends	Stock Val	Tot Ret
$91.59	$1,007.49	11	10	$404.69	$1,724.14	$2,128.83

The current dividend yield is moderate (2% to 4% ranges) at 3.09%. The 5, 10 and historical median dividend yields are also moderate at 2.76%, 2.79% and 2.46%. The dividend increases for the last 5 years is low (less than 8% per year) at 5.8% per year. The last dividend increase was for 4.2% and it occurred in 2024.

The Dividend Payout Ratios (DPR) are fine. The DPR for 2023 for Earnings per Share (EPS) is good at 34% with 5 year coverage at 53%. The DPR for 2023 for Adjusted Earnings per Share (AEPS) is good at 47% with 5 year coverage at 45%. The DPR for 2023 for Cash Flow per Share (CFPS) is fine at 56% with 5 year coverage at 48%, but I prefer the rate to be 40% or less. The DPR for 2023 for Free Cash Flow (FCF) is fine at 65% with 5 year coverage at 58%.

Item	Cur	5 Years
EPS	34.26%	53.48%
AEPS	47.38%	45.35%
CFPS	55.77%	47.96%
FCF	64.50%	57.59%

Debt Ratios are fine, but Liquidity Ratio is low. The Long Term Debt/Market Cap Ratio for 2023 is good at 0.07 and currently at 0.08. The Liquidity Ratio for 2023 is too low at 1.16 and 1.03 currently. If you added in Cash Flow after dividends, the ratios are still low at 1.40 and currently at 1.27. I prefer these ratios to be at 1.50 or higher. The Debt Ratio for 2023 is good at 1.70 and 1.65 currently. The Leverage and Debt/Equity Ratios for 2023 are fine at 2.44 and 1.44 and currently at 2.54 and 1.54.

Type	Year End	Ratio Curr
Lg Term R	0.07	0.08
Intang/GW	0.19	0.22
Liquidity	1.16	1.03
Liq. + CF	1.40	1.27
Debt Ratio	1.70	1.65
Leverage	2.44	2.54
D/E Ratio	1.44	1.54

The Total Return per year is shown below for years of 5 to 35 to the end of 2023 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.
2018	5	6.03%	6.97%	3.96%	3.01%
2013	10	6.37%	8.63%	5.52%	3.11%
2008	15	6.97%	9.93%	6.63%	3.30%
2003	20	8.99%	8.73%	5.81%	2.92%
1998	25	9.85%	7.90%	5.42%	2.49%
1993	30	10.50%	12.86%	9.19%	3.67%
1988	35	11.21%	14.12%	10.15%	3.97%

The Total Return per year is shown below for years of 5 to 35 to the end of 2023 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From	Years	Div. Gth	Tot Ret	Cap Gain	Div.
2018	5	5.18%	6.24%	3.32%	2.92%
2013	10	8.48%	11.32%	7.84%	3.47%
2008	15	7.18%	10.29%	7.18%	3.11%
2003	20	8.59%	8.59%	5.94%	2.66%
1998	25	10.61%	6.94%	4.77%	2.17%
1993	30	10.22%	12.70%	9.17%	3.54%
1988	35	11.47%	14.75%	10.57%	4.18%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 20.17, 24.17, and 26.01. The corresponding 10 year ratios are 19.88, 22.55 and 24.50. The corresponding historical ratios are 16.55, 19017 and 21.97. The current ratio is 22.29 based on a stock price of $160.61 and EPS estimate for 2024 of $7.20. This ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 14.68, 16.72 and 18.31. The corresponding 10 year ratios are 14.62, 16.39 and 18.24. The corresponding 10 year ratios are 19.88, 22.55 and 24.50. The current ratio is 16.14 based on a stock price of $160.61 and AEPS estimate for 2024 of $9.95. This ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $80.78. The 10-year low, median, and high median Price/Graham Price Ratios are 1.83, 2.04 and 2.26. The current ratio is 1.99 based on a stock price of $160.61. This ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median. I get a 10-year median Price/Book Value per Share Ratio of 5.70. The current P/B Ratio is 5.51 based on a Book Value of $70,158M, Book Value per Share of $29.15 and a stock price of $160.61. The current ratio is 3% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have a Book Value per Share estimate for 2024 of $30.08. This implies a P/B Ratio of 5.34 with a Book Value of $72,405M, and a stock price of $160.61. This ratio is 6% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 15.77. The current P/CF Ratio is 15.75 based on Cash Flow per Share estimate for 2024 of $10.20, Cash Flow of $24,552M and a stock price of $160.61. The current ratio is 0.2% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get an historical median dividend yield of 2.46%. The current dividend yield is 3.09% based on dividends of $4.96 and stock price of $160.61. The current dividend yield is 26% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

I get a 10 year median dividend yield of 2.79%. The current dividend yield is 3.09% based on dividends of $4.96 and stock price of $160.61. The current dividend yield is 10% above the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively reasonable and below the median.

The 10-year median Price/Sales (Revenue) Ratio is 4.36. the current P/S Ratio is 4.35 based on Revenue estimate for 2024 of $88,786M, Revenue per Share of $36.89 and a stock price of $160.61. The current ratio is 0.2% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median. Results of stock price testing is that the stock price is pointing to a reasonable price that is below the median. The 10 year dividend yield test says that the stock price is reasonable and below the median. The P/S Ratio test confirms this. Practically all the testing is saying the same thing.

When I look at analysts’ recommendations, I find Strong Buy (7), Buy (3), and Hold (13). The consensus would be a Buy. The 12 months consensus stock price is $174.28 with a high of $215.00 and low of $155.00. The 12 month stock price of $174.28 implies a total return of 11.60% with 8.51% from capital gains and 3.09% from dividends based on a current stock price of $160.61.

Some analysts on Stock Chase like this stock and think it is a buy and other do not like it. Mainly it is not liked because of disappointing results and because Healthcare is a tough business. Stock Chase gives this company 5 stars out of 5. Tony Dong on Motley Fool thinks you should buy this stock as it has increased its dividends for over 50 consecutive years. Kay Ng on Motley Fool thinks you should own this conservative stock in your RRSP. The company put out a Press Release about their fourth quarter of 2023. The company put out a Press Release about their third quarter of 2024.

There is a Bloomberg report on Yahoo Finance about the Talc Court case. Simply Wall Street via Yahoo Finance reviews this stock. Simply Wall Street has one warning on this stock of large one-off items impacting financial results. This is why your have Adjusted Earnings per Share.

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, and medical devices divisions. They sold off their consumer products divisions. Its web site is here Johnson and Johnson.

The last stock I wrote about was about was Cenovus Energy Inc (TSX-CVE, NYSE-CVE) ... learn more. The next stock I will write about will be Innergex Renewable Energy (TSX-INE, OTC-INGXF) ... learn more on Monday, November 4, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.